Please Wait
Applying Filters...
menu
    • menu

    U.S. Patents

    PharmaCompass Sponsored Ads

    Virtual Booth

    Post An Enquiry

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    VB

    Post An Enquiry

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Xls

    CATEGORY PAGE
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2SALERNO PHARMS

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    SALERNO PHARMS

    SIMVASTATIN

    arrow
    Pharmex
    Not Confirmed

    SALERNO PHARMS

    Country
    arrow
    Pharmex
    Not Confirmed

    Patent Expiration Date : 2027-04-26

    SIMVASTATIN

    US Patent Number : 10300041

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 206679

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2027-04-26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    SALERNO PHARMS

    SIMVASTATIN

    arrow
    Pharmex
    Not Confirmed

    SALERNO PHARMS

    Country
    arrow
    Pharmex
    Not Confirmed

    Patent Expiration Date : 2027-04-26

    SIMVASTATIN

    US Patent Number : 10300041

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 206679

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2027-04-26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF